Novartis AG
SIX:NOVNEE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
SIX:NOVNEE
|
CH |
|
Leonteq AG
OTC:LNTQF
|
CH |
|
Realty Income Corp
NYSE:O
|
US |
|
S
|
Sony Group Corp
F:SONA
|
JP |
|
A
|
Applied Materials Inc
SWB:AP2
|
US |
|
M
|
Meta Platforms Inc
SGO:FB
|
US |
|
M
|
MOL Magyar Olajes Gazipari Nyrt
WSE:MOL
|
HU |
|
Secom Co Ltd
F:XSC
|
JP |
Wall St Price Targets
NOVNEE Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOVNEE is 126.09 CHF with a low forecast of 95.85 CHF and a high forecast of 150.53 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVNEE's stock price target?
Price Target
126.09
CHF
According to Wall Street analysts, the average 1-year price target for NOVNEE is 126.09 CHF with a low forecast of 95.85 CHF and a high forecast of 150.53 CHF.
What is the Revenue forecast for Novartis AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for Novartis AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 12%.
